10th Clinical Oncology Update – ONCOLOGY 2018
Scientific Program
Saturday, 16 June 2018
9.00–9.10 | Opening |
Session I |
Melanoma and other skin malignancies |
| 9.10–9.30 | Current standard therapy in skin malignancies Prof. Wojciech Wysocki (Poland) |
| 9.30–9.50 | The future of therapy in skin malignanies Dr Tomasz Świtaj (Poland) |
Session II |
Gynecological and urological malignancies |
| 9.50–10.10 | Current standard therapy in ovarian cancer patients Prof. Paweł Blecharz (Poland) |
| 10.10–10.30 | The future of therapy in ovarian cancer patients Prof. Paweł Blecharz (Poland) |
| 10.30–10.50 | Current standard therapy in prostate and kidney cancer Dr Paweł Potocki (Poland) |
| 10.50–11.10 | The future of therapy in protaste and kidney cancer Dr Paweł Potocki (Poland) |
Session III |
Supportive care |
| 11.10–11.30 | Current standard of antiemetic drugs, granulocyte colony-stimulating factors and erythropoiesis-stimulating agents Dr Agnieszka Jagiełło-Gruszfeld (Poland) |
| 11.30–12.00 | |
Session IV |
Breast and lung cancer |
| 12.00–12.20 | Current standard therapy in lung cancer patients Dr Magdalena Knetki-Wróblewska (Poland) |
| 12.20–12.40 | The future of therapy in lung cancer patients Prof. Paweł Krawczyk (Poland) |
| 12.40–13.00 | Current standard therapy in breast cancer patients Dr Katarzyna Pogoda (Poland) |
| 13.00–13.20 | The future of therapy in breast cancer patients Dr Agnieszka Jagiełło-Gruszfeld (Poland) |
Session V |
Gastrointestinal malignancies |
| 13.20–13.40 | Current standard therapy in colorectal cancer patients Prof. Andrzej Rutkowski (Poland) |
| 13.40–14.00 | The future of therapy in colorectal cancer patients Prof. Piotr Potemski (Poland) |
| 14.00–14.20 | Current standard therapy in gastric and pancreatic cancer patients Prof. Piotr Potemski (Poland) |
| 14.20–14.40 | The future of therapy in gastric and pancreatic cancer patients Dr Joanna Streb (Poland) |
| 14.40–14.50 | Closing |
| 14.50 | Lunch |